Focus
MRHA
UK Becomes First Country to Approve Crispr Gene Editing Therapy
The first-of-its-kind gene-editing tool for sickle cell disease was accelerated to market through a regulatory initiative.
Regulator Didn’t Tell Public About Post COVID-19 Vaccination Myocarditis for Four Months
The MHRA said it needed to assess data from multiple sources before adding warnings to COVID shots.
